Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease

JAMA Neurology

Volumn 75, Issue 1, 2018, Pages 65-71

  Hamid, Shahd H M ^a   Whittam, Dan ^a   Saviour, Mariyam ^b   Alorainy, Amal ^c   Mutch, Kerry ^a   Linaker, Samantha ^a   Solomon, Tom ^c   Bhojak, Maneesh ^a   Woodhall, Mark ^d   Waters, Patrick ^d   Appleton, Richard ^e   Duddy, Martin ^f   Jacob, Anu ^a  

^a THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^f ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; CARBAMAZEPINE; IMMUNOGLOBULIN G; LEVETIRACETAM; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PREDNISOLONE; AQUAPORIN 4;

ADULT; ARTICLE; ATAXIC APHASIA; CAUCASIAN; CHILD; CLINICAL ARTICLE; CONFUSION; CONSULTATION; CONTROLLED STUDY; DEMYELINATION; ENCEPHALITIS; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; IMMUNOGLOBULIN G DEFICIENCY; MALE; MIDDLE AGED; MYELITIS; OPTIC NEURITIS; PHOTOPHOBIA; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; TONIC CLONIC SEIZURE; VOMITING; ADOLESCENT; AGED; BLOOD; EUROPE; IMMUNOLOGY; SEIZURE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AQUAPORIN 4; ENCEPHALITIS; EUROPE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; RETROSPECTIVE STUDIES; SEIZURES; YOUNG ADULT;

EID: 85040253705     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2017.3196     Document Type: Article

References (23)

1. Ramanathan S, Dale RC, Brilot F. Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev. 2016;15(4):307-324.
2. McLaughlin KA, Chitnis T, Newcombe J, et al. Age-dependent B cell autoimmunity to amyelin surface antigen in pediatric multiple sclerosis. J Immunol. 2009;183(6):4067-4076.
3. Kitley J, Woodhall M, Waters P, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology. 2012;79(12):1273-1277.
4. Mader S, Gredler V, Schanda K, et al. Complement activating antibodies tomyelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation. 2011;8:184.
5. Reindl M, Rostasy K. MOG antibody-associated diseases. Neurol Neuroimmunol Neuroinflamm. 2015;2(1):e60.
6. Jarius S, Kleiter I, Ruprecht K, et al; Neuromyelitis Optica Study Group (NEMOS). MOG-IgG in NMO and related disorders: a multicenter study of 50 patients: part 3, brainstem involvement-frequency, presentation and outcome. J Neuroinflammation. 2016;13(1):281.
7. Wingerchuk DM, Banwell B, Bennett JL, et al; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-189.
8. Hamid SH, Elsone L, Mutch K, Solomon T, Jacob A. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates. Mult Scler. 2017;23(2):228-233.
9. Hino-Fukuyo N, Haginoya K, Nakashima I, et al. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies. Brain Dev. 2015;37(9):849-852.
10. Tsuburaya RS, Miki N, Tanaka K, et al. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis. Brain Dev. 2015;37(1):145-148.
11. Ramberger M, Bsteh G, Schanda K, et al. NMDA receptor antibodies: a rare association in inflammatory demyelinating diseases. Neurol Neuroimmunol Neuroinflamm. 2015;2(5):e141.
12. Titulaer MJ, Höftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;75(3):411-428.
13. Ogawa R, Nakashima I, Takahashi T, et al. MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm. 2017;4(2):e322.
14. Fujimori J, Takai Y, Nakashima I, et al. Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry. 2017;88(6):534-536.
15. Numa S, Kasai T, Kondo T, et al. An adult case of anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated multiphasic acute disseminated encephalomyelitis at 33-year intervals. Intern Med. 2016;55(6):699-702.
16. Jarius S, Ruprecht K, Kleiter I, et al; Optica Study Group (NEMOS). MOG-IgG in NMO and related disorders: a multicenter study of 50 patients: part 2, epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016;13(1):280.
17. Waters P, Woodhall M, O'Connor KC, et al. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm. 2015;2(3):e89.
18. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012;78(9): 665-671.
19. Hacohen Y, Absoud M, Deiva K, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm. 2015;2(2):e81.
20. Nakano H, Tanaka M, Kinoshita M, et al. Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica. Epilepsy Res. 2013;104(1-2):175-180.
21. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology. 2008;71(2):93-100.
22. Lotze TE, Northrop JL, Hutton GJ, Ross B, Schiffman JS, Hunter JV. Spectrum of pediatric neuromyelitis optica. Pediatrics. 2008;122(5):e1039-e1047.
23. Chitnis T, Ness J, Krupp L, et al. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. 2016;86 (3):245-252.